We provide experienced guidance to optimize access planning and initiatives and build internal engagement. This includes:
- Developing access frameworks and tactical blueprints
- Internal access capacity building
- Country and product prioritization
- Opportunity mapping
- Access program feasibility studies
We create sustainable access strategies rooted in real market potential and supported by validated access indicators. This includes:
- Patient affordability assessments
- Willingness to pay and prescribe studies
- Commercial market access strategies
- Stakeholder engagement strategies
We enable continuous access program optimization through strategic performance and outcome reviews. This includes:
- Patient and KOL perspectives & stakeholder research
- Real-World Insights (RWI) generation
- Policy shaping
- Access to Medicines Index submission preparation
We systematically analyze program data to derive valuable insights aimed at enhancing patient access initiatives in order to:
- Optimize the patient journey and patient experience
- Inform clinical and policy healthcare decision-making
- Guide healthcare system improvements
- Identify new unmet needs and improve patient health outcomes